Key result
Patients with cardiovascular disease had significantly higher odds of currently using heated tobacco products compared to those without the disease (OR 2.29).
Why the study?
Patients with chronic diseases have difficulty quitting smoking and may initiate heated tobacco products, but their use patterns in this population needed examination.
Are people with chronic diseases more likely to use heated tobacco products compared to those without?
Cross-Sectional (n=9,008)
Are people with chronic diseases more likely to use heated tobacco products compared to those without?
People with chronic diseases, including cardiovascular disease, are significantly more likely to use heated tobacco products and engage in dual use with cigarettes.
Answers are grounded in this paper and cite their sources.
Chronic disease patients show higher HTP uptake, often with cigarettes; leaves open cessation benefit or harm reduction in CVD.
Heated tobacco products (HTPs) have become popular recently. People with chronic disease, such as diabetes, cardiovascular disease (CVD), chronic obstructive pulmonary disease (COPD) and cancer, should quit smoking for treatment and recurrence of tobacco-related diseases. However, they have difficulty in quitting smoking, and they may start HTPs use to quit smoking. The purpose of this study is to examine the use of HTPs in people with chronic disease. We used data from an internet study, the Japan Society and New Tobacco Internet Survey (JASTIS). We analyzed 9,008 respondents aged 15-73 years in 2019 using logistic regression. Current use of tobacco products was defined as use within the previous 30 days. Prevalence of current HTP use including dual use and dual use with cigarettes was 9.0% and 6.1% respectively in total. By disease: hypertension 10.2% and 7.4%, diabetes 15.9% and 12.3%, CVD 19.2% and 15.7%, COPD 40.5% and 33.3%, and cancer 17.5% and 11.9%. Diabetes, CVD, COPD, and cancer were positively associated with current use of HTPs (odds ratios (ORs) and 95% confidence intervals (CIs): 1.48 (1.06, 2.07), 2.29 (1.38, 3.80), 3.97(1.73, 9.11), and 3.58(1.99, 6.44), respectively) and dual use of cigarettes and HTPs (ORs and 95% CIs: 2.23 (1.61, 3.09), 3.58 (2.29, 5.60), 7.46 (3.76, 14.80), and 2.57 (1.46, 4.55), respectively) after adjusting for confounders. People with chronic disease were more likely to use HTPs and HTPs together with cigarettes. Further research on the smoking situation of HTPs in patients with chronic diseases is necessary.
No takes yet. Share an insight, caveat, or question.
Nakama et al. (2021) conducted a cross-sectional in Chronic diseases (including cardiovascular disease, diabetes, COPD, and cancer) (n=9,008). Cardiovascular disease vs. No cardiovascular disease was evaluated on Current use of heated tobacco products (within previous 30 days) (OR 2.29, 95% CI 1.38-3.80, p=<0.01). Patients with cardiovascular disease had significantly higher odds of currently using heated tobacco products compared to those without the disease (OR 2.29).
Synapse has enriched 10 related papers. Consider them for comparative context: